All posts

Look for better things from BSM Technologies starting with Q2, says Laurentian

BSM Technologies CEO Aly Rahemtulla.

Improved operating leverage should drive better results for BSM Technologies (BSM Technologies Stock Quote, Chart, News: TSXV:GPS) starting with the company’s second quarter results, says Laurentian Bank Securities analyst Nick Agostino.

On Wednesday after market close, BSM Technologies will report its Q2, 2015 results. Agostino thinks the company will post EBITDA of $865,000 on revenue of $8.1-million.

Agostino expects BSM will see from benefit from outsourcing its hardware, particularly with regard to gross margins. He thinks this will take full effect over the next two quarters, when older inventory is exhausted and new, higher margin products begin to comprise a larger portion of the overall mix.

The analyst believes things are on the upswing for BSM.

“With a view that FQ1 sales were a trough for the company and management’s commentary that the F2014 investment phase is now complete, we expect FQ2 results to highlight the onset of operating leverage, along with margins expansion noted above, to help drive EBITDA margins toward the 20% level over the coming quarters,” said Agostino. “With that, we forecast QoQ revenue growth of 3.5% vs. opex growth of 1.8% yielding EBITDA margins of 10.6%, up 60bps QoQ.”

In a research update to clients today, Agostino maintained his “Buy” rating and one year target of $2.25, implying a return of 136.8% at the time of publication.

More Cantech Analysts

Tagged with: gps
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Small cap stocks are still cheap, this investor says

Nationwide’s chief market strategist Mark Hackett told CNBC’s Worldwide Exchange on Dec. 3 that survey data may look weak, but… [Read More]

2 days ago

Microbot Medical is a buy, Roth says

Roth Capital Markets initiated coverage of Microbot Medical (Microbot Medical Stock Quote, Chart, News, Analysts, Financials NASDAQ:MBOT) with a “Buy”… [Read More]

2 days ago

Texas could be big for these pot stocks, analyst says

Beacon Securities analyst Russell Stanley said Texas is “getting bigger for cannabis operators” after the state’s Department of Public Safety… [Read More]

2 days ago

Bank of Nova Scotia is the cheapest bank stock, this analyst says

RBC Dominion Securities analyst Darko Mihelic said Bank of Nova Scotia’s (Bank of Nova Scotia Stock Quote, Chart, News, Analysts,… [Read More]

2 days ago

This analyst just raised his price target on Marvell Technology

Marvell Technology (Marvell Technology Stock Quote, Chart, News, Analysts, Financials NASDAQ:MRVL) reported largely in-line fiscal third-quarter results and offered longer-term… [Read More]

3 days ago

Is Curaleaf still a buy?

Beacon Securities analyst Russell Stanley maintained his “Buy” rating and C$5.00 price target on Curaleaf Holdings (Curaleaf Holdings Stock Quote,… [Read More]

3 days ago